KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Cash from Investing Activities (2018 - 2025)

Historic Cash from Investing Activities for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to -$42.7 million.

  • Progyny's Cash from Investing Activities fell 37824.5% to -$42.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$92.3 million, marking a year-over-year decrease of 43693.22%. This contributed to the annual value of $195.8 million for FY2024, which is 19763.97% up from last year.
  • Progyny's Cash from Investing Activities amounted to -$42.7 million in Q3 2025, which was down 37824.5% from -$29.9 million recorded in Q2 2025.
  • Progyny's Cash from Investing Activities' 5-year high stood at $86.1 million during Q2 2024, with a 5-year trough of -$94.6 million in Q1 2025.
  • For the 5-year period, Progyny's Cash from Investing Activities averaged around -$10.9 million, with its median value being -$1.9 million (2022).
  • Per our database at Business Quant, Progyny's Cash from Investing Activities surged by 34457.8% in 2021 and then tumbled by 786368.29% in 2023.
  • Over the past 5 years, Progyny's Cash from Investing Activities (Quarter) stood at -$6.3 million in 2021, then surged by 81.42% to -$1.2 million in 2022, then crashed by 7863.68% to -$93.4 million in 2023, then surged by 180.28% to $75.0 million in 2024, then plummeted by 157.0% to -$42.7 million in 2025.
  • Its Cash from Investing Activities was -$42.7 million in Q3 2025, compared to -$29.9 million in Q2 2025 and -$94.6 million in Q1 2025.